CPV 732xxx

Cyprus – Development consultancy services – ΥΔΠ(2)/004/2025 ΔΙΑΓΩΝΙΣΜΟΣ ΓΙΑ ΠΑΡΟΧΗ ΥΠΗΡΕΣΙΩΝ ΔΙΕΥΘΥΝΤΗ ΕΡΓΟΥ (PROJECT MANAGER) ΓΙΑ ΚΑΤΑΣΚΕΥΑΣΤΙΚΑ ΕΡΓΑ ΤΟΥ ΤΕΧΝΟΛΟΓΙΚΟΥ ΠΑΝΕΠΙΣΤΗΜΙΟΥ ΚΥΠΡΟΥ

Latvia – Research and development consultancy services – Liepājas valstspilsētas un Dienvidkurzemes novada attīstības programmas 2022.-2027.gadam vidusposma novērtējums

Moldova – Development consultancy services – Project Implementation Support

Norway – Research and development consultancy services – Commercialisation services

Spain – Development consultancy services – Servicio de gestión del centro metodológico deportivo

Portugal – Research consultancy services – EMERGENCIES – European sentinel monitoring of acute drug-related harm

Estonia – Research consultancy services – Riigi ühtse majandustarkvara versioonivahetuse eelanalüüs (RTK)

Ireland – Research and development consultancy services – MCC Provision of Services for Audit of Oral Heritage Recordings for County Mayo – Phase 2

China – Research and development consultancy services – Technical assistance to "Understanding Chinese Legal Reform (EUCLERA) 2025-2030"

Spain – Development consultancy services – Prórroga extraordinaria Oficina Técnica de Sostenibilidad. Clave del expediente: 2025R370008. Referencia Servicio de Contratación: 2025-00161, relacionado con 2021-00269, 2023-00096, 2024-00146 y 2024-00276.

Belgium – Research and development consultancy services – Wetenschappelijke studie Argusvlinder Linkerscheldeoever

Lithuania – Research consultancy services – 15780_Ekspertinių vertinimų, dalyvaujant Europos vaistų agentūros mokslinio patarimo procedūroje Nr. 243531, pirkimas

Norway – Research and development consultancy services – Independent inspections with project implementation, technical assistance and capacity building.

Portugal – Research and development consultancy services – EU-QUALITY - Development of a quality management system for drug demand reduction in Europe

Lithuania – Research consultancy services – 15523_Ekspertinių vertinimų, dalyvaujant Europos vaistų agentūros mokslinio patarimo procedūroje Nr. 237952, pirkimas